Axsome Therapeutics (AXSM) EBIT Growth (3y) (2018 - 2026)
Axsome Therapeutics (AXSM) EBIT Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - | - |
| 10 | Axsome Therapeutics | 12.32 Bn | 12.02 Bn | 176.48 Mn | -115.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -115.01% |
| Dec 31, 2025 | 23.37% |
| Sep 30, 2025 | -2.83% |
| Jun 30, 2025 | 2.14% |
| Mar 31, 2025 | -14.17% |
| Dec 31, 2024 | -30.59% |
| Sep 30, 2024 | -23.30% |
| Jun 30, 2024 | -36.26% |
| Mar 31, 2024 | -34.19% |
| Dec 31, 2023 | -52.44% |
| Sep 30, 2023 | -43.26% |
| Jun 30, 2023 | -54.10% |
| Mar 31, 2023 | 41.89% |
| Dec 31, 2022 | -34.86% |
| Sep 30, 2022 | -30.81% |
| Jun 30, 2022 | -42.82% |
| Mar 31, 2022 | -54.31% |
| Dec 31, 2021 | -75.99% |
| Sep 30, 2021 | -59.43% |
| Jun 30, 2021 | -56.88% |